|
Originally published In Press as doi:10.1074/jbc.M104794200 on June 15, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32008-32015, August 24, 2001
Nuclear Factor B Is a Molecular Target for
Sulforaphane-mediated Anti-inflammatory Mechanisms*
Elke
Heiss,
Christian
Herhaus,
Karin
Klimo,
Helmut
Bartsch, and
Clarissa
Gerhäuser
From the Deutsches Krebsforschungszentrum Heidelberg, Division of
Toxicology and Cancer Risk Factors, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Sulforaphane (SFN), an aliphatic isothiocyanate,
is a known cancer chemopreventive agent. Aiming to investigate
anti-inflammatory mechanisms of SFN, we here report a potent decrease
in lipopolysaccharide (LPS)-induced secretion of pro-inflammatory and
pro-carcinogenic signaling factors in cultured Raw 264.7 macrophages
after SFN treatment, i.e. NO, prostaglandin E2,
and tumor necrosis factor . SFN did not directly interact with NO,
nor did it inhibit inducible nitric-oxide synthase enzymatic activity.
Western blot analyses revealed time- and dose-dependent
reduction of LPS-induced inducible nitric-oxide synthase as well as
Cox-2 protein expression, which was suppressed at the transcriptional
level. To reveal the target of SFN beyond its anti-inflammatory action,
we performed electrophoretic mobility shift assay analyses of
transcription factor-DNA binding. Consequently, nuclear factor B
(NF- B), a pivotal transcription factor in LPS-stimulated
pro-inflammatory response, was identified as the key mediator. SFN
selectively reduced DNA binding of NF- B without interfering with
LPS-induced degradation of the inhibitor of NF- B nor with nuclear
translocation of NF- B. Because SFN can interact with thiol groups by
dithiocarbamate formation, it may impair the redox-sensitive DNA
binding and transactivation of NF- B. Sulforaphane could either
directly inactivate NF- B subunits by binding to essential Cys
residues or interact with glutathione or other redox regulators like
thioredoxin and Ref-1 relevant for NF- B function. Our data provide
novel evidence that anti-inflammatory mechanisms contribute to
sulforaphane-mediated cancer chemoprevention.
*
This work was supported by Verein zur Förderung der
Krebsforschung in Deutschland e.V. These data were presented in
part at the 90th Annual Meeting of the American Association
of Cancer Research, April 10-14, 1999 in Philadelphia, PA (68).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom requests for reprints should be addressed: DKFZ
Heidelberg, C0202 Chemoprevention, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Tel.: 49-6221-42-33-06; Fax:
49-6221-42-33-59; E-mail: c.gerhauser@dkfz.de.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-Y. Cho, F. Imani, L. Miller-DeGraff, D. Walters, G. A. Melendi, M. Yamamoto, F. P. Polack, and S. R. Kleeberger
Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
138 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, A. T. Dinkova-Kostova, and P. Talalay
Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles
PNAS,
October 14, 2008;
105(41):
15926 - 15931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Innamorato, A. I. Rojo, A. J. Garcia-Yague, M. Yamamoto, M. L. de Ceballos, and A. Cuadrado
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
J. Immunol.,
July 1, 2008;
181(1):
680 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pappa, J. Strathmann, M. Lowinger, H. Bartsch, and C. Gerhauser
Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro
Carcinogenesis,
July 1, 2007;
28(7):
1471 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Gasper, M. Traka, J. R. Bacon, J. A. Smith, M. A. Taylor, C. J. Hawkey, D. A. Barrett, and R. F. Mithen
Consuming Broccoli Does Not Induce Genes Associated with Xenobiotic Metabolism and Cell Cycle Control in Human Gastric Mucosa
J. Nutr.,
July 1, 2007;
137(7):
1718 - 1724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pledgie-Tracy, M. D. Sobolewski, and N. E. Davidson
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines
Mol. Cancer Ther.,
March 1, 2007;
6(3):
1013 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Yore, K. T. Liby, T. Honda, G. W. Gribble, and M. B. Sporn
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-{kappa}B activation through direct inhibition of I{kappa}B kinase {beta}
Mol. Cancer Ther.,
December 1, 2006;
5(12):
3232 - 3239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Thomson, K. K. Brown, J. M. Pullar, and M. B. Hampton
Phenethyl Isothiocyanate Triggers Apoptosis in Jurkat Cells Made Resistant by the Overexpression of Bcl-2.
Cancer Res.,
July 1, 2006;
66(13):
6772 - 6777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Karuri, Y. Huang, S. Bodreddigari, C. H. Sutter, B. D. Roebuck, T. W. Kensler, and T. R. Sutter
3H-1,2-Dithiole-3-thione Targets Nuclear Factor {kappa}B to Block Expression of Inducible Nitric-Oxide Synthase, Prevents Hypotension, and Improves Survival in Endotoxemic Rats
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
61 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dey, D. Ribnicky, A. G. Kurmukov, and I. Raskin
In Vitro and in Vivo Anti-Inflammatory Activity of a Seed Preparation Containing Phenethylisothiocyanate
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
326 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bertl, H. Bartsch, and C. Gerhauser
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention.
Mol. Cancer Ther.,
March 1, 2006;
5(3):
575 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Xu, G. Shen, X. Yuan, J.-h. Kim, A. Gopalkrishnan, Y.-S. Keum, S. Nair, and A.-N. T. Kong
ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells
Carcinogenesis,
March 1, 2006;
27(3):
437 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Kwak, J. S. Song, J. Y. Heo, S. D. Yang, J.-Y. Nam, and H. G. Cheon
Roflumilast Inhibits Lipopolysaccharide-Induced Inflammatory Mediators via Suppression of Nuclear Factor-{kappa}B, p38 Mitogen-Activated Protein Kinase, and c-Jun NH2-Terminal Kinase Activation
J. Pharmacol. Exp. Ther.,
December 1, 2005;
315(3):
1188 - 1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dasgupta, M. Jana, X. Liu, and K. Pahan
Myelin Basic Protein-primed T Cells of Female but Not Male Mice Induce Nitric-oxide Synthase and Proinflammatory Cytokines in Microglia: IMPLICATIONS FOR GENDER BIAS IN MULTIPLE SCLEROSIS
J. Biol. Chem.,
September 23, 2005;
280(38):
32609 - 32617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Dinkova-Kostova, K. T. Liby, K. K. Stephenson, W. D. Holtzclaw, X. Gao, N. Suh, C. Williams, R. Risingsong, T. Honda, G. W. Gribble, et al.
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
PNAS,
March 22, 2005;
102(12):
4584 - 4589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kumagai, N. Matsukawa, Y. Kaneko, Y. Kusumi, M. Mitsumata, and K. Uchida
A Lipid Peroxidation-derived Inflammatory Mediator: IDENTIFICATION OF 4-HYDROXY-2-NONENAL AS A POTENTIAL INDUCER OF CYCLOOXYGENASE-2 IN MACROPHAGES
J. Biol. Chem.,
November 12, 2004;
279(46):
48389 - 48396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-A. Pham, J. W. Jacobberger, A. D. Schimmer, P. Cao, M. Gronda, and D. W. Hedley
The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice
Mol. Cancer Ther.,
October 1, 2004;
3(10):
1239 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Carcinogenesis,
September 1, 2004;
25(9):
1629 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-C. Chen, Y.-S. Chang, J.-C. Kang, M.-J. Hsu, J.-R. Sheu, T.-L. Chen, C.-M. Teng, and C.-H. Lin
Peptidoglycan Induces Nuclear Factor-{kappa}B Activation and Cyclooxygenase-2 Expression via Ras, Raf-1, and ERK in RAW 264.7 Macrophages
J. Biol. Chem.,
May 14, 2004;
279(20):
20889 - 20897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Miyoshi, S. Takabayashi, T. Osawa, and Y. Nakamura
Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis
Carcinogenesis,
April 1, 2004;
25(4):
567 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dasgupta, M. Jana, X. Liu, and K. Pahan
Role of Very-late Antigen-4 (VLA-4) in Myelin Basic Protein-primed T Cell Contact-induced Expression of Proinflammatory Cytokines in Microglial Cells
J. Biol. Chem.,
June 13, 2003;
278(25):
22424 - 22431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Howells, B. Gallacher-Horley, C. E. Houghton, M. M. Manson, and E. A. Hudson
Indole-3-carbinol Inhibits Protein Kinase B/Akt and Induces Apoptosis in the Human Breast Tumor Cell Line MDA MB468 but not in the Nontumorigenic HBL100 Line
Mol. Cancer Ther.,
November 1, 2002;
1(13):
1161 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gerhauser, A. Alt, E. Heiss, A. Gamal-Eldeen, K. Klimo, J. Knauft, I. Neumann, H.-R. Scherf, N. Frank, H. Bartsch, et al.
Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop
Mol. Cancer Ther.,
September 1, 2002;
1(11):
959 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Basten, Y. Bao, and G. Williamson
Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells
Carcinogenesis,
August 1, 2002;
23(8):
1399 - 1404.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|